%0 Journal Article %J Eur J Immunol %D 2011 %T Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. %A Passerini, Laura %A Di Nunzio, Sara %A Gregori, Silvia %A Gambineri, Eleonora %A Cecconi, Massimiliano %A Seidel, Markus G %A Cazzola, Giantonio %A Perroni, Lucia %A Tommasini, Alberto %A Vignola, Silvia %A Guidi, Luisa %A Roncarolo, Maria G %A Bacchetta, Rosa %K Cell Differentiation %K Cell Lineage %K Cells, Cultured %K Enteritis %K Forkhead Transcription Factors %K Genetic Diseases, X-Linked %K Humans %K Immunity, Innate %K Interleukin-2 Receptor alpha Subunit %K Mutation %K Polyendocrinopathies, Autoimmune %K Syndrome %K T-Lymphocytes, Regulatory %X

Mutations of forkhead box p3 (FOXP3), the master gene for naturally occurring regulatory T cells (nTregs), are responsible for the impaired function of nTregs, resulting in an autoimmune disease known as the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. The relevance of other peripheral tolerance mechanisms, such as the presence and function of type 1 regulatory T (Tr1) cells, the major adaptive IL-10-producing Treg subset, in patients with IPEX syndrome remains to be clarified. FOXP3(mutated) Tr1-polarized cells, differentiated in vitro from CD4(+) T cells of four IPEX patients, were enriched in IL-10(+) IL-4(-) IFN-γ(+) T cells, a cytokine production profile specific for Tr1 cells, and expressed low levels of FOXP3 and high levels of Granzyme-B. IPEX Tr1 cells were hypoproliferative and suppressive, thus indicating that FOXP3 mutations did not impair their function. Furthermore, we isolated Tr1 cell clones from the peripheral blood of one FOXP3(null) patient, demonstrating that Tr1 cells are present in vivo and they can be expanded in vitro in the absence of WT FOXP3. Overall, our results (i) show that functional Tr1 cells differentiate independently of FOXP3, (ii) confirm that human Tr1 and nTregs are distinct T-cell lineages, and (iii) suggest that under favorable conditions Tr1 cells could exert regulatory functions in IPEX patients.

%B Eur J Immunol %V 41 %P 1120-31 %8 2011 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21400500?dopt=Abstract %R 10.1002/eji.201040909 %0 Journal Article %J Clin Exp Rheumatol %D 2010 %T Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. %A Olivito, Biagio %A Taddio, Andrea %A Simonini, Gabriele %A Massai, Cristina %A Ciullini, Sara %A Gambineri, Eleonora %A de Martino, Maurizio %A Azzari, Chiara %A Cimaz, Rolando %K Acute Disease %K Child %K Child, Preschool %K Female %K Flow Cytometry %K Forkhead Transcription Factors %K Genotype %K Humans %K Immunoglobulins, Intravenous %K Infant %K Italy %K Male %K Mucocutaneous Lymph Node Syndrome %K Polymorphism, Single Nucleotide %K Reverse Transcriptase Polymerase Chain Reaction %K RNA, Messenger %K T-Lymphocytes, Regulatory %X

OBJECTIVES: The aims of this study were: 1) to investigate forkhead box P3 (FOXP3) expression in patients with Kawasaki disease (KD), exploring possible differences during the acute phase and after defervescence; 2) to evaluate a possible association of the FOXP3 single nucleotide polymorphism (SNP) 543 (SNP ID: rs2232367) with KD.

METHODS: FOXP3 expression was evaluated on 8 children with KD and 15 healthy children by flow cytometry and Real-Time polymerase chain reaction (RT-PCR). FOXP3 SNP 543 was genotyped by denaturing high-performance liquid chromatography (DHPLC) and sequencing on DNA samples from 58 additional children with KD and 114 healthy donors.

RESULTS: The frequencies of CD4+CD25 +FOXP3+ regulatory T cells were significantly (p=0.0002) lower during the acute phase of KD than in sex- and age-matched healthy donors (median % + SD: 4.8+/-1.3 vs. 7.7+/-1.7) and a similar tendency was revealed for FOXP3 mRNA transcripts (p<0.0001). FOXP3 expression increased significantly, at both protein and mRNA levels, after intravenous immunoglobulin (IVIG) therapy treatment and achieving complete remission of disease (at least 48 hrs; median 9.5 days, range 2-30). Of the 58 patients screened, only one female subject (1.7%) carried the presence of 543 SNP in heterozygosis (C>T; for a total of 1 allele out of 88), with no difference between KD patients and controls (0.0%, 0/203 alleles).

CONCLUSIONS: Our data reinforce the notion of an impaired immunoregulation in KD, suggesting also a role of IVIG treatment in modifying the Treg compartment. FOXP3 SNP 543 does not seem to be involved in susceptibility to KD in Italian children.

%B Clin Exp Rheumatol %V 28 %P 93-7 %8 2010 Jan-Feb %G eng %N 1 Suppl 57 %1 http://www.ncbi.nlm.nih.gov/pubmed/20412712?dopt=Abstract